AstraZeneca PLC

AZNNYSE • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
163.31 USD
↗ 1.81 (1.12%)🟢PRE MARKET (AS OF 04:40 AM EDT)
🟢Market: OPEN

Shares of AstraZeneca PLC (AZN) are trading at $163.31. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages. On the valuation front, AZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Aug 5, 2026.

Open?$161.91
High?$163.91
Low?$161.91
Prev. Close?$161.50
Volume?17.9K
Avg. Volume?3.5M
VWAP?$163.36
Rel. Volume?0.01x
Bid / Ask
Bid?$163.39 × 100
Ask?$163.52 × 800
Spread?$0.13
Midpoint?$163.45
Valuation & Ratios
Market Cap?250.5B
Shares Out?N/A
P/E Ratio?172.62
P/B Ratio?16.86
EPS?$0.94
Dividend?0.00%
Ex-Dividend?2026-08-07
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Metabolic & CardiometabolicHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
96.1K
Market Cap
241.3B
Industry
N/A
Website
www.astrazeneca.com
Listed
2009-10-23
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
94
Momentum?
50
Short Sent.?
63
Piotroski F-Score?0/9Weak
Altman Z-Score?4.23Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?2.5M
Days to Cover?1.0
Avg Daily Volume3.2M
Settlement Date2026-07-15
Financial Health
Current Ratio?0.87Weak
Quick Ratio?0.72Weak
Cash Ratio?0.33Low
Debt/Equity?1.77High
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score
33/100
P/E?
Peers
11
S&P
3
172.6PRICEY▾
P/B?
Peers
33
S&P
10
16.86HIGH▾
P/S?
Peers
18
S&P
3
13.83HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
10
S&P
3
75.8HIGH▾
EV/Sales?
Peers
9
S&P
3
15.00HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
33
9.8%FAIR▾
ROA?
Peers
22
S&P
22
2.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$271.7B
Fundamentals ratios updated end of day
MarketsMoversWatchlist